Linked Life Data

20974598

Source:http://linkedlifedata.com/resource/pubmed/id/20974598

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-11
pubmed:databankReference
pubmed:abstractText
The study sought to evaluate whether topiramate prevents development of chronic daily headache (CDH, ?15 headache days per month) in adult subjects with high-frequency episodic migraine (HFEM, 9-14 migraine headache days/month). A secondary objective was to assess the efficacy of topiramate as preventive migraine treatment in this population.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1468-2982
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
18-30
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
pubmed:affiliation
Montefiore Headache Center and Department ofNeurology, Albert Einstein College of Medicine, 1165 Morris Park Ave., Bronx, NY 10461, USA. richard.lipton@einstein.yu.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study